Alcon Operating Income 2019-2024 | ALC
Alcon annual/quarterly operating income history and growth rate from 2019 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Alcon operating income for the quarter ending December 31, 2024 was $0.395B, a 89.9% increase year-over-year.
- Alcon operating income for the twelve months ending December 31, 2024 was $1.413B, a 36% increase year-over-year.
- Alcon annual operating income for 2024 was $1.413B, a 36% increase from 2023.
- Alcon annual operating income for 2023 was $1.039B, a 54.61% increase from 2022.
- Alcon annual operating income for 2022 was $0.672B, a 15.86% increase from 2021.
| Alcon Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $1,413 |
| 2023 | $1,039 |
| 2022 | $672 |
| 2021 | $580 |
| 2020 | $-482 |
| 2019 | $-187 |
| 2018 | $-248 |
| Alcon Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $395 |
| 2024-09-30 | $332 |
| 2024-06-30 | $318 |
| 2024-03-31 | $368 |
| 2023-12-31 | $208 |
| 2023-09-30 | $293 |
| 2023-06-30 | $270 |
| 2023-03-31 | $268 |
| 2022-12-31 | $21 |
| 2022-09-30 | $205 |
| 2022-06-30 | $200 |
| 2022-03-31 | $246 |
| 2021-12-31 | $182 |
| 2021-09-30 | $20 |
| 2021-06-30 | $229 |
| 2021-03-31 | $149 |
| 2020-12-31 | $141 |
| 2020-09-30 | $-129 |
| 2020-06-30 | $-466 |
| 2020-03-31 | $-28 |
| 2019-12-31 | $-68 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-53 |
| 2019-03-31 | $-48 |
| 2018-12-31 | |
| 2018-09-30 | $-284 |
| 2018-06-30 | $38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $46.824B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |